Wilson Sonsini Goodrich & Rosati advised Microchip on the transaction, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) priced an offering of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Impossible Foods in the case. Impossible Foods secured a victory in a patent infringement litigation that Impossible filed against Motif...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Cooley advised Lumos Pharma on the transaction, while Foley & Lardner advised Double Point Ventures. Lumos Pharma (NASDAQ:LUMO), a clinical...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Dropbox on the transaction, and Latham & Watkins advised Blackstone Credit & Insurance. Dropbox, Inc. (Dropbox or the Company) (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BioSapien on the transaction. BioSapien, an Abu Dhabi-based biotech startup focused on drug delivery for localized cancer treatment, announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented EzDubs in the transaction. EzDubs, a speech translation start-up using AI, announced that it has raised a $4.2 million Seed...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Axiado Corporation on the transaction. Axiado Corporation, a pioneer in hardware anchored platform security, announced it successfully raised $60 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Cimeio Therapeutics on the transaction. Cimeio Therapeutics, an immunotherapy company, announced that it has entered a research collaboration with Kyowa...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised ServiceTitam Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised the underwriters. ServiceTitan, Inc., the software platform that powers the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Dewpoint Therapeutics in the transaction. Dewpoint Therapeutics Inc., the leading biotechnology company that develops therapeutics by targeting biomolecular condensates, announced...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented BILL Holdings, Inc. in the offering, and Wilson Sonsini Goodrich & Rosati represented the initial purchasers. BILL Holdings, Inc. (NYSE: BILL), a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Nvelop Therapeutics on intellectual property matters related to the transaction. Chroma Medicine and Nvelop Therapeutics announced their merger and subsequent...
You must be a Standard 1 Year member to access this content.
